Tuesday, December 2, 2014

New York Law Firm Announces That the FDA Has Issued a Warning on the Risks Involved When Taking the Drug Xarelto

This blog title has been optimized using Keyword Winner


(PRWEB) August 12, 2014


Xarelto is an oral anticoagulant drug used to prevent blood clots, and also lowers the risk of stroke in patients who have atrial fibrillation. Xareltos official website 06/17/2014 states, People with atrial fibrillation (an irregular heart beat) are at an increased risk of forming a blood clot in the heart, which can travel to the brain, causing a stroke, or to other parts of the body. XARELTO



New York Law Firm Announces That the FDA Has Issued a Warning on the Risks Involved When Taking the Drug Xarelto

Asbestos Scare at U.S. Capitol Highlights Risk Around the Nation, Mesothelioma Law Firm Baron and Budd Reports

This blog title has been optimized using Keyword Winner


DALLAS (PRWEB) August 14, 2014


On July 10, The New York Times published a story stating that a session of the U.S. House of Representatives had to be pushed back due to concerns over the potential risk of exposure to asbestos in a portion of the Capitol Building, the mesothelioma law firm of Baron and Budd reports. Asbestos abatement work was being performed and there was a possible release of the dangerous material. This incident is a reminder that although the use of asbestos has declined substantially in the United States, it still poses a risk because it is found in hundreds of thousands of homes and buildings throughout the nation. And, most importantly, asbestos use is not banned in the U.S. (http://www.nytimes.com/2014/07/11/us/politics/possible-asbestos-risk-at-us-capitol-building.html?emc=edit_cn_20140710&nl=us&nlid=57291641&_r=0)



According to the article, U.S. Capitol Police later issued a statement that normal operations had resumed in the House portion of the Capitol. However, the East Grand staircase and a nearby meeting room would remain closed until the risk of exposure was eliminated. Exposure to asbestos can cause a wide range of health problems, including malignant pleural mesothelioma. This is an aggressive, deadly form of cancer that develops in the lining of the lungs and currently has no cure.



More than likely, if a building was constructed before 1975 it contains asbestos. An estimated 1.2 billion square feet of asbestos insulation still exists in structures throughout the U.S. Asbestos is composed of microscopic fibers that, when disturbed, can break off and become airborne. When these fibers are ingested or inhaled, they can ultimately lead to mesothelioma.



Even though the risks of exposure have been known for years and years, asbestos is, incredibly, still not banned in the United States, said Russell Budd, managing director of mesothelioma law firm Baron and Budd. As long as asbestos is allowed to be used in the U.S., people will continue to develop mesothelioma and suffer terribly as a result.



Please contact the mesothelioma law firm of Baron and Budd if you or someone close to you has been diagnosed with mesothelioma. Call 1-866-855-1229 or visit our mesothelioma-dedicated website at http://www.fightmesothelioma.com to learn about your potential legal options.



ABOUT BARON & BUDD, P.C.



The national mesothelioma law firm of Baron & Budd, P.C. has a more than 30-year history of Protecting Whats Right for asbestos sufferers and their families. As one of the first law firms to successfully litigate an asbestos lawsuit, Baron & Budd continues to actively represent veterans, industry workers and others who are suffering as a result of exposure to asbestos. Baron & Budd achieved the largest mesothelioma verdict ever in the state of Texas, a $ 55 million verdict for an asbestos sufferer and his family in El Paso, Texas. Contact Baron and Budd at 1.866.855.1229 for additional information on mesothelioma treatments, mesothelioma cancer doctors and treatment centers and mesothelioma attorneys.











Asbestos Scare at U.S. Capitol Highlights Risk Around the Nation, Mesothelioma Law Firm Baron and Budd Reports

Perrin Conferences Announces Record Registered Attendance for Asbestos Litigation Conference 2014.

This blog title has been optimized using Keyword Winner


Berwyn, PA (PRWEB) August 15, 2014


Perrin Conferences, acclaimed leader in joint plaintiff/defendant litigation conferences, today announced a record attendance of more than 425 registered participants for its sixth annual Asbestos Litigation Conference: A National Overview & Outlook. The conference will take place September 8-10, 2014, at the Fairmont San Francisco Hotel. With nearly four weeks to go, this year’s attendance is on track to beat last year’s final tally of more than 500 attendees, which was the previous all-time high for the event.


The Asbestos Litigation Conference brings asbestos insurance, legal, corporate and scientific leaders together to consider the direction and climate of current asbestos litigation.



“We are delighted to report continuous year-over-year growth in attendance for the sixth year running,” said Lynnsey Perrin, founder and CEO of Perrin Conferences. “Our numbers reflect the quality of the agenda and the high-caliber industry leaders and speakers participating at the conference. We are excited to create a wonderful experience for each of the Perrin Conference attendees.”



This year’s event will feature breakout sessions and panels covering topics such as:




Perrin Conferences Announces Record Registered Attendance for Asbestos Litigation Conference 2014.

New York Law Firm States That the FDA Announces Health Risks Involved with Patients Who Have Taken Benicar

This blog title has been optimized using Keyword Winner


Commack, New York (PRWEB) August 20, 2014


Benicar is a widely popular drug prescribed to treat hypertension/high blood pressure. Benicars active ingredient is Olmesartan, which in some cases has been shown to injure the blood cells of the small intestine. Olmesartan is also present in Benicar HCT, Tribenzor and Azor. These drugs present the same risk to the small intestine as Benicar. Some users have also experienced a significant decrease in villi, which are cells that help absorb nutrients for the body. As a result, Benicar and its active ingredient have been linked to a plethora of serious health issues including malnutrition, weight loss, dehydration, chronic diarrhea and other serious health effects. Benicar may also cause a rare gastrointestinal illness known as sprue-like enteropathy. The Food and Drug Administration has taken note of these serious conditions that may be related to Benicar. See the Food and Drug Administration Announcement (FDA, 7/3/13).



Rudolph Migliore stated “The FDA has recognized the possible gastrointestinal dangers of this widely prescribed prescription drug. It is of critical importance that doctors and patients are also made aware of how this drug works and that it may have serious side-effects.”



According to Med Page Today (7/3/13), the connection between sprue-like enteropathy and Benicar was first reported by researchers in June 2012. Twenty-two patients from 2008 to 2010 experienced what appeared to be symptoms of celiac disease. However, antibody blood tests and treatments did not support this. The symptoms of sprue-like enteropathy are mirrored by those of Celiac disease, which unlike sprue-like enteropathy is treatable by a gluten-free diet. When the symptoms arise while taking Benicar and persist extensively on a daily basis for an extended period of time, doctors often put the patient on a gluten-free diet to rule out Celiacs disease. However, doctors are finding that some patients dont respond to a gluten-free diet and that these problems are actually caused by Benicar, not Celiacs disease. See the August 2012 report of the Mayo-Clinic which discusses the Benicar connection to Sprue-Like Enteropathy and how it is different from Celiac’s disease.



Symptoms of Sprue-Like Enteropathy include all of those which Benicar users have reported as side effects (malnutrition, weight loss, etc.). The researchers initial patients experienced diarrheal illness for an average of 19 months and were, on average, 69 years old. Discontinuing the drug led to an average weight gain of 27 pounds. See the FDA Announcement (7/3/13).



If you or a loved one has been prescribed Benicar, Benicar HCT, Tribenzor or Azor and is experiencing any of the above side effects, please contact your doctor right away. The Commack, NY law firm of Rudolph F.X. Migliore, P.C. is currently investigating cases involving patients who have been prescribed Benicar and have suffered from severe, chronic diarrhea with substantial weight loss.



About the firm: The law office of Rudolph F. X. Migliore, P. C. has represented clients in a wide range of product liability cases in the last three decades and has worked with nationally recognized associated firms to reach successful verdicts. The Long Island, NY law firm of Rudolph F. X. Migliore, P. C. extends its practice of legal services to medical malpractice, defective medications, defective medical devices, asbestos, mesothelioma, and lung cancer-related cases.











New York Law Firm States That the FDA Announces Health Risks Involved with Patients Who Have Taken Benicar

New York Law Firm States That the FDA Announces Health Risks Involved with Patients Who Have Taken Benicar

This blog title has been optimized using Keyword Winner


Commack, New York (PRWEB) August 20, 2014


Benicar is a widely popular drug prescribed to treat hypertension/high blood pressure. Benicars active ingredient is Olmesartan, which in some cases has been shown to injure the blood cells of the small intestine. Olmesartan is also present in Benicar HCT, Tribenzor and Azor. These drugs present the same risk to the small intestine as Benicar. Some users have also experienced a significant decrease in villi, which are cells that help absorb nutrients for the body. As a result, Benicar and its active ingredient have been linked to a plethora of serious health issues including malnutrition, weight loss, dehydration, chronic diarrhea and other serious health effects. Benicar may also cause a rare gastrointestinal illness known as sprue-like enteropathy. The Food and Drug Administration has taken note of these serious conditions that may be related to Benicar. See the Food and Drug Administration Announcement (FDA, 7/3/13).



Rudolph Migliore stated “The FDA has recognized the possible gastrointestinal dangers of this widely prescribed prescription drug. It is of critical importance that doctors and patients are also made aware of how this drug works and that it may have serious side-effects.”



According to Med Page Today (7/3/13), the connection between sprue-like enteropathy and Benicar was first reported by researchers in June 2012. Twenty-two patients from 2008 to 2010 experienced what appeared to be symptoms of celiac disease. However, antibody blood tests and treatments did not support this. The symptoms of sprue-like enteropathy are mirrored by those of Celiac disease, which unlike sprue-like enteropathy is treatable by a gluten-free diet. When the symptoms arise while taking Benicar and persist extensively on a daily basis for an extended period of time, doctors often put the patient on a gluten-free diet to rule out Celiacs disease. However, doctors are finding that some patients dont respond to a gluten-free diet and that these problems are actually caused by Benicar, not Celiacs disease. See the August 2012 report of the Mayo-Clinic which discusses the Benicar connection to Sprue-Like Enteropathy and how it is different from Celiac’s disease.



Symptoms of Sprue-Like Enteropathy include all of those which Benicar users have reported as side effects (malnutrition, weight loss, etc.). The researchers initial patients experienced diarrheal illness for an average of 19 months and were, on average, 69 years old. Discontinuing the drug led to an average weight gain of 27 pounds. See the FDA Announcement (7/3/13).



If you or a loved one has been prescribed Benicar, Benicar HCT, Tribenzor or Azor and is experiencing any of the above side effects, please contact your doctor right away. The Commack, NY law firm of Rudolph F.X. Migliore, P.C. is currently investigating cases involving patients who have been prescribed Benicar and have suffered from severe, chronic diarrhea with substantial weight loss.



About the firm: The law office of Rudolph F. X. Migliore, P. C. has represented clients in a wide range of product liability cases in the last three decades and has worked with nationally recognized associated firms to reach successful verdicts. The Long Island, NY law firm of Rudolph F. X. Migliore, P. C. extends its practice of legal services to medical malpractice, defective medications, defective medical devices, asbestos, mesothelioma, and lung cancer-related cases.











New York Law Firm States That the FDA Announces Health Risks Involved with Patients Who Have Taken Benicar

$17.7 Million Dollar Verdict for Spouse of Lung Cancer Victim

This blog title has been optimized using Keyword Winner


Los Angeles, CA (PRWEB) August 21, 2014


On July 30, 2014 a jury in Los Angeles County Superior Court returned a verdict in favor of Mrs. Tajie Major, the widow of retired Captain William Major, U.S. Navy, against Lorillard Tobacco Co. for $ 17.736 M (Tajie Major vs. Lorillard Tobacco Co., Case No. BC473650). Plaintiffs counsels, Gil Purcell and Jason Rose of Novato, CA-based Brayton Purcell LLP were understandably pleased with the result for Mrs. Major. Mr. Purcell wished to express his gratitude for the assistance his client received from those who appeared in court during the trial: “We are most appreciative of the witnesses with the courage and resolve to come forward and mete out some justice against [Lorillard Tobacco Co.]” The unanimous 12-0 jury verdict found that Mr. Majors use of Lorillard Tobacco Co.s Kent cigarettes, of Micronite Filter fame, and Newport cigarettes, Lorillard Tobacco Co.s menthol brand, caused his death at the age of 55.



The month-long trial brought an end to the present phase of this case which was filed in 1999 and includes a hiatus of several years in its history (3). As to his client and her persistence over the time that her case has been pending, Mr. Purcell noted Tajie Major is to be commended.



Purcell further commented that in this case “The jury was superb in their commitment to do the right thing based on the evidence and law.” In rendering judgment against Lorillard Tobacco Co., the jury had to confront the plaintiffs argument that a cigarette was not just tobacco rolled in paper, but instead was a highly engineered, mass produced, complex device, as well that all cigarettes were not created equal. The jury also received evidence from the plaintiff that demonstrated that Lorillard Tobacco Co.s Kent and Newport products were meticulously designed to create and sustain an addiction to nicotine (3).



Mrs. Major argued that Lorillard Tobacco Co. expanded vast resources to assess the effects of content manipulation and adulteration not only of tobacco itself and the additives to it, but also of the paper that encased the tobacco and the filters through which smoke was inhaled into the lungs. Ultimately, the jury heard how design changes which could have made significant differences in the health impact and safety of their consumers were ignored by Lorillard Tobacco Co (3).



Through much of this same evidence, the jury unanimously concluded that Mr. Majors lung cancer and death were caused both by the fact that Kent and Newport cigarettes were negligently designed, and that smoking the products created overwhelming and unreasonable risks of harm for the consuming public, like Mr. Major. (2). By their verdict today, the jury unanimously concluded that Kent and Newport cigarettes, made by Lorillard Tobacco Co., failed to meet the California consumer safety based risk-benefit test for design defect.



Unable to assess punitive damages in this wrongful death case, the jury nevertheless found that Mrs. Major had sustained economic loss of $ 2.15M for the financial support her terminally ill husband could no longer provide. Because of his premature death, they also determined she was entitled to recover an additional $ 430,000 in related and other lost benefits, and $ 156,700 for lost household services. Having been married for over 20 years by the time of his death (1), the jury further determined that $ 10M was an appropriate figure to compensate Mrs. Major for the loss of her husband which she had already sustained, and that an additional $ 5M was proper for the future loss she would endure because of Mr. Majors wrongful death. Liability was determined by the jury and Lorillard Tobacco Co. was assessed fault at 17%, while Mr. Major comparative fault was determined to be 50% (3). Other cigarette companies were assessed a 33% share of fault (1) and, despite arguments by Lorillard Tobacco Co. to the contrary, the jury found that possible prior exposure to asbestos played no role in the causation of disease and assigned that agent a 0.0% fault allocation (3).



To prove up Mrs. Majors case, Mr. Purcell and Mr. Rose utilized two noted local physicians: Pulmonologist Barry Horn, M.D. from Alta Bates Hospital in Berkeley, and UC Berkeley Epidemiologist, Alan Smith, M.D. Also testifying in the case was Seattle, WA, pathologist, Samuel P. Hammar, M.D., and one of Mr. Majors treating physicians, Dr. Ronald Miller. These witnesses helped to establish the basic facts of the lung cancer that caused William Majors death. A former Phillip Morris Co. cigarette design engineer, William Farone, PhD., provided testimony which established that design options utilized by cigarette manufacturers, including Lorillard Tobacco Co., exposed users of their products to hundreds of toxic substances and scores of carcinogens, thereby increasing the risks of disease and death to their customers in the process. Such evidence further demonstrated that such risks were avoidable or subject to substantial reduction by known design alternatives, which were ignored by the manufacturers like Lorillard Tobacco Co. Dr. James DiFranza also testified about the addictive properties of nicotine based upon his years of experience in dealing with addicted smokers. James Mills, PhD, an economist, provided the expert testimony upon which the jury relied as the basis to calculate the economic loss Mrs. Major had suffered. Additionally, testimony of numerous witnesses was presented to establish the nature and extent of Mr. Majors use of Lorillard Tobacco Co.s cigarette products.



Assisting the trial team of Gil Purcell and Jason Rose were Brayton Purcell LLP attorney Stephanie Drenski and John Wallace, Of Counsel to the firm.



Opposing Mr. Purcell and Mr. Rose before the Honorable Judge Amy Hogue (LASC,


Dept.: 322) on behalf of Lorillard Tobacco Co., were the St. Louis firm of Thompson Coburn LLP, by Carl L. Rowley and DLA Piper LLP (US) by San Diego partner Brian Foster.



Total verdict: $ 17,736,700.


1) Palos Verdes Estates widow wins lawsuit against cigarette company, Daily Breeze, July 30, 2014, http://www.dailybreeze.com/general-news/20140730/palos-verdes-estates-widow-wins-lawsuit-against-cigarette-company



2) Naval Captains Widow Wins Big Tobacco Verdict, Los Angeles Daily Journal, August 1, 2014, http://www.braytonlaw.com/Firm-Overview/News/Naval-Captains-Widow-Wins-Big-Tobacco-Verdict.shtml (scan of physical document)



3) Lorillard Must Pay $ 4M In Wrongful Death Suit, Jury Says, August 4, 2014, Law360, https://www.law360.com/articles/563977/lorillard-must-pay-4m-in-wrongful-death-suit-jury-says



4) Tajie Major vs. Lorillard Tobacco Co., Case No. BC473650, Case Summary, Los Angeles Superior Court, http://www.lasuperiorcourt.org/civilcasesummarynet/ui/casesummary.aspx











$17.7 Million Dollar Verdict for Spouse of Lung Cancer Victim

Acclaimed Author Lionel Shriver Supports Mesothelioma Awareness Day

This blog title has been optimized using Keyword Winner


Alexandria, VA (PRWEB) August 25, 2014


The Mesothelioma Applied Research Foundation (Meso Foundation) released today a video of award-winning author, Lionel Shriver, in which Ms. Shriver urges viewers to observe September 26th as Mesothelioma Awareness Day. The video can be watched on the Meso Foundations YouTube channel.



Several years ago, one of my closest friends, was diagnosed with mesothelioma, says Ms. Shriver in the video. Her experience of living with the disease, and ultimately dying from it, moved me to write my tenth novel, So Much for That.



So Much for That is a novel that tackles the complicated topic of healthcare in the United States, through the experience of a mesothelioma patient and her family.



In the video, viewers are urged to visit the organizations website, curemeso.org, to learn more about Mesothelioma Awareness Day.



Ms. Shriver is best known as the author of the award-winning novel We Need to Talk About Kevin, and Big Brother.



Mesothelioma Awareness Day is a grassroots movement established in 2004 by volunteers of the Meso Foundation with the goal of bringing more attention and funding to this historically-neglected cancer.



On behalf of the mesothelioma community, I am infinitely grateful to Ms. Shriver for her help in raising awareness, said nurse practitioner and executive director of the Mesothelioma Applied Research Foundation, Mary Hesdorffer.



More awareness of this disease and the consequent increased funding for research, education, support, and advocacy is exactly what is needed to help us save lives, added Ms. Hesdorffer.



Mesothelioma is a malignant tumor of the lining of the lung, abdomen, or heart known to be caused by exposure to asbestos. With the life expectancy of less than one year after diagnosis, medical experts consider it one of the most aggressive and deadly of all cancers. An estimated one-third of those who develop mesothelioma were exposed while serving in the Navy or working in shipyards. Currently, few treatment options exist. There is no cure.



ABOUT THE MESOTHELIOMA APPLIED RESEARCH FOUNDATION


The Meso Foundation is the only 501(c)(3) nonprofit organization dedicated to eradicating mesothelioma and easing the suffering caused by this cancer. The Meso Foundation actively seeks philanthropic support to fund mesothelioma research; provide patient support services and education; and advocate Congress for increased federal funding for mesothelioma research. The Meso Foundation is the only non-government funder of peer-reviewed scientific research to develop life-saving treatments for this extremely aggressive cancer. To date, the Foundation has awarded over $ 8.7 million to research. More information is available at http://www.curemeso.org.



###











Acclaimed Author Lionel Shriver Supports Mesothelioma Awareness Day

Mesothelioma Victims Center Points To A New Study Involving Biomarkers As A Possible Breakthrough For Getting Individuals Diagnosed Earlier For this Rare Form Of Cancer

This blog title has been optimized using Keyword Winner


(PRWEB) August 26, 2014


The Mesothelioma Victims Center is 100% focused on making certain all diagnosed victims of mesothelioma and their family receives the best possible compensation for this rare form of cancer caused by exposure to asbestos. They are also doing everything possible to create more awareness of mesothelioma, and the need for early detection for individuals exposed to asbestos at work decades ago. This early detection includes annual chest x-rays, to ensure a worker who had heavy exposure to abestos decades ago does not have masses, or benign tumors on their lungs. The Victims Center noticed a recent article about early detection of mesothelioma that gave them hope about possible early detection. This article was focused on biomarkers.



According to June 6th 2014 article by Chromatography Today, “A team at the Copenhagen University Hospital in Denmark has identified four biomarkers which could help identify between malignant pleural mesothelioma (MPM) and non-cancerous pleural tissue with reactive mesothelial proliferations (RMPs). This is a common but difficult diagnostic problem in pleural biopsy samples taken from patients who have suspected MPM. The ability to make quicker and more accurate diagnoses could help improve patient outcomes. http://www.chromatographytoday.com/news/bioanalytical/40/breaking_news/biomarkers_distinguish_between_mesothelioma_and_non-cancer/30370/#sthash.rfrjvLmg.dpuf



The Mesothelioma Victims Center says, The study, which was published in the Journal of Molecular Diagnostics, aimed to find micro RNA’s, which are small, non-coding RNA strands made of around 22 nucleotides. They were of interest as previous research has shown their ability to be diagnostic, prognostic and predictive markers in other cancers. We are urging individuals who had heavy exposure to asbestos in a power plant, a oil refinery, a manufacturing facility, in while serving in the US Navy to have annual physical exams that include a x-ray, because the sooner this disease is diagnosed the better the treatment options, and potential compensation for the victim.”



For more information about their unsurpassed free services, diagnosed victims of mesothelioma or their family members are urged to contact the Mesothelioma Victims Center at 866-714-6466.



Information About Mesothelioma For Diagnosed Victims And Their Families From The Mesothelioma Victims Center:



According to the US Center for Disease Control the average age for a diagnosed victim of mesothelioma is 72 years old. Frequently victims of mesothelioma are initially misdiagnosed with pneumonia. This year between 2500, and 3000 US citizens will be diagnosed with mesothelioma. Mesothelioma is attributable to exposure to asbestos.



The states with the highest incidence of mesothelioma include Pennsylvania, Maine, New Jersey, West Virginia, Florida, Wyoming, and Washington. However, based on the calls the Mesothelioma Victims Center receives diagnosed victims could be in any state including California, New York, Texas, Massachusetts, Maryland, Virginia, North Carolina, Georgia, Louisiana, Missouri, Ohio, Michigan, Iowa, Indiana, Illinois, Wisconsin, Minnesota, North Dakota, Montana, Nebraska, Kansas, Colorado, Utah, New Mexico, Arizona, Nevada, Idaho, Oregon, and Alaska.



High risk work groups for exposure to asbestos include US Navy Veterans, shipyard workers, oil refinery workers, power plant workers, manufacturing, or industrial workers, plumbers, electricians, auto mechanics, machinists, or construction workers. Typically the exposure to asbestos occurred in the 1950s, 1960s, 1970s, or 1980s. http://MesotheliomaVictimsCenter.Com



The Mesothelioma Victims Center says, Before you hire a mesothelioma attorney please call us at 866-714-6466, and compare the qualifications of who we consider to be the nation’s most skilled mesothelioma attorneys to any other lawyer, or law firm. When it comes to obtaining the best mesothelioma settlement, the quality of the attorney matters, as we would like to explain.” http://MesotheliomaVictimsCenter.Com



For more information about a rare form of cancer caused by exposure to asbestos called mesothelioma, please visit the US Centers For Disease Control’s web site: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5815a3.htm











Mesothelioma Victims Center Points To A New Study Involving Biomarkers As A Possible Breakthrough For Getting Individuals Diagnosed Earlier For this Rare Form Of Cancer

New Clinical Trial: Using the Listeria Virus to Fight Mesothelioma

This blog title has been optimized using Keyword Winner


Alexandria, VA (PRWEB) August 28, 2014


On September 10, the Mesothelioma Applied Research Foundation (Meso Foundation) will interview Stephen Isaacs, the chairperson, president and CEO of Aduro BioTech, during a new installment of the Foundations Meet the Mesothelioma Experts live broadcast. The interview will be led by the Meso Foundations executive director and mesothelioma expert nurse practitioner, Mary Hesdorffer, APRN.



The focus of the interview will be Aduro BioTechs experimental therapy for malignant pleural mesothelioma, known as CRS-207. CRS-207 is a weakened form of the Listeria virus modified to reduce its ability to cause infections, but still able to stimulate the immune system.



The interview will be available live on September 10, at 1 PM ET, by calling into a conference-call number. The interview is free of charge, but listeners must RSVP ahead of time by visiting http://www.curemeso.org/experts in order to receive a call-in number.



In his position at Aduro BioTech, Mr. Isaacs initiated the companys current immunotherapy program based on attenuated strains of Listeria monocytogenes. He was responsible for recruiting key members of the current vaccine team with deep expertise in the biology of Listeria. Mr. Isaacs has published over 20 peer-reviewed scientific articles and is an inventor on over 40 issued patents.



Mesothelioma is a malignant tumor of the lining of the lung, abdomen, or heart known to be caused by exposure to asbestos. With the life expectancy of less than one year after diagnosis, medical experts consider it one of the most aggressive and deadly of all cancers. An estimated one-third of those who develop mesothelioma were exposed while serving in the Navy or working in shipyards. Currently, few treatment options exist. There is no cure.



ABOUT THE MESOTHELIOMA APPLIED RESEARCH FOUNDATION


The Meso Foundation is the only 501(c)(3) nonprofit organization dedicated to eradicating mesothelioma and easing the suffering caused by this cancer. The Meso Foundation actively seeks philanthropic support to fund mesothelioma research; provide patient support services and education; and advocate Congress for increased federal funding for mesothelioma research. The Meso Foundation is the only non-government funder of peer-reviewed scientific research to develop life-saving treatments for this extremely aggressive cancer. To date, the Foundation has awarded over $ 8.7 million to research. More information is available at http://www.curemeso.org.



###











New Clinical Trial: Using the Listeria Virus to Fight Mesothelioma

Cancer Research Funding Organization Now Accepts Bitcoin Donations

This blog title has been optimized using Keyword Winner


Alexandria, VA (PRWEB) August 28, 2014


Starting on Monday, the Mesothelioma Applied Research Foundation (Meso Foundation) is able to accept donations in Bitcoin, in addition to all the traditional ways to give. The Bitcoin donation page can be found at http://www.curemeso.org/bitcoin.



As more and more businesses are accepting Bitcoin as a form of payment, we decided it was important for us to do the same, said Meso Foundations chief executive officer, Melinda Kotzian.



Bitcoin is an online-only, internet currency, started in 2009. Bitcoin donations can be easily, and immediately following a donation, converted into any other currency, including the US Dollar.



We do not want anything to stand in our way of raising funds to fund mesothelioma research, education, support, and advocacy. Our goal is to save lives, and well do whatever it takes to get there, Ms. Kotzian added.



Mesothelioma is a malignant tumor of the lining of the lung, abdomen, or heart known to be caused by exposure to asbestos. With the life expectancy of less than one year after diagnosis, medical experts consider it one of the most aggressive and deadly of all cancers. An estimated one-third of those who develop mesothelioma were exposed while serving in the Navy or working in shipyards. Currently, few treatment options exist. There is no cure.



ABOUT THE MESOTHELIOMA APPLIED RESEARCH FOUNDATION


The Meso Foundation is the only 501(c)(3) nonprofit organization dedicated to eradicating mesothelioma and easing the suffering caused by this cancer. The Meso Foundation actively seeks philanthropic support to fund mesothelioma research; provide patient support services and education; and advocate Congress for increased federal funding for mesothelioma research. The Meso Foundation is the only non-government funder of peer-reviewed scientific research to develop life-saving treatments for this extremely aggressive cancer. To date, the Foundation has awarded over $ 8.7 million to research. More information is available at http://www.curemeso.org.


###











Cancer Research Funding Organization Now Accepts Bitcoin Donations

Mesothelioma Applied Research Foundations Annual Report 2013 Release

This blog title has been optimized using Keyword Winner


Alexandria, VA (PRWEB) August 28, 2014


On August 21, the Mesothelioma Applied Research Foundation (Meso Foundation) released its 2013 Annual Report, featuring the organizations audited financial information, as well as details about its 2013 programs.



According to the report, in 2013, the Meso Foundation spent 86 cents on every dollar on programs versus 14 cents on fundraising and administration.



The Meso Foundation strives to keep costs to a minimum, wrote the Foundations chief executive officer, Melinda Kotzian.



As a result of the Foundations fiscal responsibility, we have been recognized as a four-star charity through Charity Navigator, named an accredited charity by the Better Business Bureau, and awarded the prestigious 2013 Top-Rated Award for GreatNonprofits, Ms. Kotzian added.



The Meso Foundation is also listed through the National Cancer Institute as a mesothelioma support service organization, an honor attributed only to a select number of national nonprofit organizations that fit very strict criteria.



In addition to education, support services for patients and their families, and advocacy for increased federal funding of mesothelioma research, the Meso Foundation lists its total research funding at $ 8.7 million, which to date has yielded 180 articles published in 83 scientific journals.



The Mesothelioma Applied Research Foundations 2013 Annual Report is available on the organizations website at http://www.curemeso.org/annualreports.



Mesothelioma is a malignant tumor of the lining of the lung, abdomen, or heart known to be caused by exposure to asbestos. With the life expectancy of less than one year after diagnosis, medical experts consider it one of the most aggressive and deadly of all cancers. An estimated one-third of those who develop mesothelioma were exposed while serving in the Navy or working in shipyards. Currently, few treatment options exist. There is no cure.



ABOUT THE MESOTHELIOMA APPLIED RESEARCH FOUNDATION


The Meso Foundation is the only 501(c)(3) nonprofit organization dedicated to eradicating mesothelioma and easing the suffering caused by this cancer. The Meso Foundation actively seeks philanthropic support to fund mesothelioma research; provide patient support services and education; and advocate Congress for increased federal funding for mesothelioma research. The Meso Foundation is the only non-government funder of peer-reviewed scientific research to develop life-saving treatments for this extremely aggressive cancer. To date, the Foundation has awarded over $ 8.7 million to research. More information is available at http://www.curemeso.org.


###











Mesothelioma Applied Research Foundations Annual Report 2013 Release

Organization to Raise Awareness of Mesothelioma on the Today Show

This blog title has been optimized using Keyword Winner


Alexandria, VA (PRWEB) August 29, 2014


For the fifth year in a row, the Mesothelioma Applied Research Foundation (Meso Foundation) will be observing September 26th as Mesothelioma Awareness Day, by attending the Today show on Rockefeller Plaza, in New York.



Members of the community who wish to join are encouraged to RSVP. The Foundation will be providing t-shirts and signs to participating community members.



In the past years, mesothelioma community members have received attention from Al Roker and Savannah Guthrie.



Mesothelioma Awareness Day, established by Meso Foundation volunteers in 2004, has been the driving force behind the movement to bring more attention and funding to this cancer.



In the last ten years, through various activities, the Meso Foundation and its volunteers have been able to obtain “National Mesothelioma Awareness Day” proclamations by both the U.S. Senate and the House of Representatives, have raised nearly a million dollars, have received local government proclamations in their states and localities, and have received dozens of instances of media coverage for their stories, events, and activities.



Mesothelioma is a malignant tumor of the lining of the lung, abdomen, or heart known to be caused by exposure to asbestos. With the life expectancy of less than one year after diagnosis, medical experts consider it one of the most aggressive and deadly of all cancers. An estimated one-third of those who develop mesothelioma were exposed while serving in the Navy or working in shipyards. Currently, few treatment options exist. There is no cure.



ABOUT THE MESOTHELIOMA APPLIED RESEARCH FOUNDATION


The Meso Foundation is the only 501(c)(3) nonprofit organization dedicated to eradicating mesothelioma and easing the suffering caused by this cancer. The Meso Foundation actively seeks philanthropic support to fund mesothelioma research; provide patient support services and education; and advocate Congress for increased federal funding for mesothelioma research. The Meso Foundation is the only non-government funder of peer-reviewed scientific research to develop life-saving treatments for this extremely aggressive cancer. To date, the Foundation has awarded over $ 8.7 million to research. More information is available at http://www.curemeso.org.


###











Organization to Raise Awareness of Mesothelioma on the Today Show

New York Law Firm Discusses Allegedly Dangerous Surgical Morcellator Devices And Cancer Risk

This blog title has been optimized using Keyword Winner


New York (PRWEB) September 02, 2014


Based on new studies, concerns over Surgical Morcellator devices, commonly used during hysterectomy, kidney and spleen surgeries, have continued to mount. These devices may spread cancerous cells and harm patients.



An article in the “Public Library of Science” written by Michael A. Seidman, Titilope Oduyebo and Bradley J. Quade called, “Peritoneal Dissemination Complicating Morcellation of Uterine Mesenchymal Neoplasms” published on Nov 26, 2012 defines a morcellator as a surgical instrument used for the removal of large masses of tissues during laparoscopic surgery. When inserted into the body, the device works by rotating its blades and breaking large tissue down into small fragments. For an example, in laparoscopic hysterectomy the womans uterus is minced up, or morcellated, into smaller pieces inside the woman’s belly cavity in order to remove from the abdomen.



When woman undergo this surgery and may have previously undiagnosed cancer or sarcoma, this can cause a serious risk of the device spreading cancerous cells inside the body. A study from the Journal of the American Medical Association released in March 2014, along with the highly publicized story in May 2014 specifically in “Prevention.com,” of a 40 year old doctor from Boston who herself has developed cancer after undergoing a hysterectomy morcellation procedure named Amy Reed, has caused the medical community questioning whether or not morcellators pose a serious threat to the health of women.



In April 2014 the FDA stated an announcement that discouraged the use of morcellators to remove the uterus or uterine fibroids. As of April 2014 FDA records indicate that morcellators are used in thousands of hysterectomies per year, and 1 in 350 women may be at risk due to undiagnosed cancer that they had during the surgery. In many cases, women discovered that they later had aggressive, late stage cancer after their surgeons had used morcellators. Men are also at risk for the same disease-spreading complication, although morcellators are usually used in kidney or spleen procedures. Previously undetected cancers may also spread into the abdomen. Aside from cancerous tissue spreading, morcellators can also disperse benign tissues throughout the abdomen. If these tissues grow on other organs, it may lead to pain, bowel obstruction, and infection.



If you or a loved one has had a laparoscopic surgical procedure with a morcellator device, it is advised to follow up with a doctor for routine checkups. If you have developed cancer after undergoing a laparoscopic surgical procedure with a morcellator device, contact the law firm of Rudolph F.X. Migliore, P.C. for a free case evaluation.



About the firm: The law office of Rudolph F. X. Migliore, P. C. has represented clients in a wide range of product liability cases in the last three decades and has worked with nationally recognized associated firms to reach successful verdicts. The Long Island, NY law firm of Rudolph F. X. Migliore, P. C. extends its practice of legal services to Medical Malpractice, Defective Medications, Defective Medical Devices, Asbestos, Mesothelioma and Lung Cancer-related cases.











New York Law Firm Discusses Allegedly Dangerous Surgical Morcellator Devices And Cancer Risk

Mesothelioma Victims Center Points To Recent US Capital Shutdown As Indication That Many Older Buildings Can Still Put People At Risk For Exposure To Asbestos

This blog title has been optimized using Keyword Winner


(PRWEB) September 03, 2014


The Mesothelioma Victims Center says, “It is amazing to think the possibility of light exposure to asbestos could actually shut down the US Congress, but that is exactly what happened on July 10th of 2014. Today, whole buildings are shut down at the slightest possibility of asbestos, as opposed to no action being taken decades ago for workers exposed to the toxic and damaging effects of asbestos on a daily basis. What this shows is that in the 1950’s, 1960’s, 1970’s, and for a good portion of the 1980’s many workers in the United States simply had no idea that asbestos was bad for their health. Through research and education, groups like ours have been spreading the word on just how bad this stuff really is.



From ThinkProgress.org and the Washington Times:


“On Thursday July 10th 2014, the House side of the U.S. Capitol was shut down due to a possible spill of asbestos that occurred while workers were cleaning out the hazardous material from the building.


Something fell during asbestos abatement work at the Capitol overnight, prompting the closure of the House side of the building. Hazardous material response teams and Environmental Protection Agency investigators are conducting testing at the scene to determine whether or not the material that fell exposed the area to asbestos.



For attribution please read: http://thinkprogress.org/climate/2014/07/10/3458586/epa-regulations-bill-asbestos-incident-capitol/



The Mesothelioma Victims Center says, Breathing in asbestos fibers, which can be found in old insulation, flooring, roofing, paint, and fabrics, can cause lung disease and lung cancer, or mesothelioma. The EPA has taken multiple regulatory actions against asbestos use over the last few decades, including banning it from pipe insulation and sprays.”



While past exposure to asbestos cannot be undone, with respect to asbestos exposure for US citizens, the Center is encouraging individuals who were exposed to asbestos in the workplace decades ago to get annual checkups for masses or benign tumors inside their lungs. The Center is also strongly encouraging individuals who have been diagnosed with this rare form of cancer, or their family members, to call them anytime at 866-714-6466 to ensure they are dealing with the nation’s most skilled mesothelioma attorneys and have information on the very best treatment options possible. http://MesotheliomaVictimsCenter.Com



Before any diagnosed victim of mesothelioma retains an attorney to advance a mesothelioma compensation claim, please call the Mesothelioma Victims Center at 866-714-6466 and ask what sets the group apart from any other mesothelioma center. http://MesotheliomaVictimsCenter.Com



Information About Mesothelioma For Diagnosed Victims And Their Families From The Mesothelioma Victims Center:



High risk work groups for exposure to asbestos include US Navy Veterans, shipyard workers, oil refinery workers, power plant workers, manufacturing workers, plumbers, electricians, auto mechanics, machinists, or construction workers. Typically the exposure to asbestos occurred in the 1950s, 1960s, 1970s, or 1980s. http://MesotheliomaVictimsCenter.Com



According to the US Center for Disease Control the average age for a diagnosed victim of mesothelioma is 72 years old. Frequently victims of mesothelioma are initially misdiagnosed with pneumonia. This year between 2500, and 3000 US citizens will be diagnosed with mesothelioma. Mesothelioma is attributable to exposure to asbestos.



According to the CDC, the states with the highest incidence of mesothelioma include Pennsylvania, Maine, New Jersey, West Virginia, Florida, Wyoming, and Washington. However, based on the calls the Mesothelioma Victims Center receives diagnosed victims could be in any state including California, New York, Texas, Massachusetts, Maryland, Virginia, North Carolina, Georgia, Louisiana, Missouri, Ohio, Michigan, Iowa, Indiana, Illinois, Wisconsin, Minnesota, Montana, Nebraska, Kansas, Colorado, Utah, New Mexico, Arizona, Nevada, Idaho, Oregon, and Alaska.



The Mesothelioma Victims Center says, Before you hire a mesothelioma attorney please call us at 866-714-6466, and compare the qualifications of who we consider to be the nation’s most skilled mesothelioma attorneys to any other lawyer, or law firm. When it comes to obtaining the best mesothelioma compensation settlement, the quality of the attorney matters, as we would like to explain anytime.” http://MesotheliomaVictimsCenter.Com



For more information about a rare form of cancer caused by exposure to asbestos called mesothelioma, please visit the US Centers For Disease Control’s web site: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5815a3.htm











Mesothelioma Victims Center Points To Recent US Capital Shutdown As Indication That Many Older Buildings Can Still Put People At Risk For Exposure To Asbestos

Mesothelioma Victims Center Points To Lack Of Workplace Rules Regarding Asbestos Exposure Prior To The 1980s As Further Proof For The Need Of Annual Healthcare Screening

This blog title has been optimized using Keyword Winner


(PRWEB) September 05, 2014


The Mesothelioma Victims Center says, “Based on all of our research and nearly a decade of helping diagnosed victims of mesothelioma get instant access to the nation’s top mesothelioma compensation attorneys and treatment options specialists, we’ve concluded that the reason most victims have mesothelioma might be due to the lack of OSHA many decades ago. In the 1950s, 1960s, 1970s, and early 1980s there were basically no federal rules when it came to asbestos exposure and what was deemed safe or toxic.



Updated OSHA Asbestos Standards As of April 1st, 2014:


Asbestos hazards are addressed in specific standards for general industry and shipyard employment. This section highlights OSHA standards, preambles to final rules (background to final rules), Federal Registers (rules, proposed rules, and notices), directives (instructions for compliance officers), standard interpretations (official letters of interpretation of the standards) related to asbestos. https://www.osha.gov/SLTC/asbestos/standards.html



According to the Mesothelioma Victims Center, “Asbestos rules are now extremely stringent and thorough. If workplace exposure to asbestos is not properly reported, there can be huge fines or even prison time. As we would like to explain to any family or individual dealing with a mesothelioma diagnosis, we cannot undo your exposure but we can make certain you have instant access to the nation’s most skilled mesothelioma compensation attorneys and treatment option specialists whose expertise is available nationwide.”



For more information a diagnosed victim of mesothelioma, or their family members can contact the Mesothelioma Victims Center anytime at 866-714-6466. http://MesotheliomaVictimsCenter.Com



Information About Mesothelioma For Diagnosed Victims And Their Families From The Mesothelioma Victims Center



According to the US Center for Disease Control the average age for a diagnosed victim of mesothelioma is 72 years old. Frequently victims of mesothelioma are initially misdiagnosed with pneumonia. This year between 2500 and 3000 US citizens will be diagnosed with mesothelioma. Mesothelioma is attributable to exposure to asbestos.



The states with the highest incidence of mesothelioma include Pennsylvania, Maine, New Jersey, West Virginia, Florida, Wyoming, and Washington. However, based on the calls the Mesothelioma Victims Center receives diagnosed victims could be in any state including California, New York, Texas, Massachusetts, Maryland, Virginia, North Carolina, Georgia, Louisiana, Missouri, Ohio, Michigan, Iowa, Indiana, Illinois, Wisconsin, Minnesota, North Dakota, Montana, Nebraska, Kansas, Colorado, Utah, New Mexico, Arizona, Nevada, Idaho, Oregon, and Alaska.



High risk work groups for exposure to asbestos include US Navy Veterans, shipyard workers, oil refinery workers, power plant workers, manufacturing, or industrial workers, plumbers, electricians, auto mechanics, machinists, or construction workers. Typically the exposure to asbestos occurred in the 1950s, 1960s, 1970s, or 1980s. http://MesotheliomaVictimsCenter.Com



The Mesothelioma Victims Center says, Before you hire a mesothelioma attorney please call us at 866-714-6466, and compare the qualifications of who we consider to be the nation’s most skilled mesothelioma attorneys to any other lawyer, or law firm. When it comes to obtaining the best mesothelioma settlement, the quality of the attorney matters, as we would like to explain.” http://MesotheliomaVictimsCenter.Com



For more information about a rare form of cancer caused by exposure to asbestos called mesothelioma, please visit the US Centers For Disease Control’s web site: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5815a3.htm











Mesothelioma Victims Center Points To Lack Of Workplace Rules Regarding Asbestos Exposure Prior To The 1980s As Further Proof For The Need Of Annual Healthcare Screening

New Study Finds Aspirin May Delay Mesothelioma Development in Mice, Reports Surviving Mesothelioma

Raleigh, NC (PRWEB) September 05, 2014


Scientists at the University of Western Australia have found that non-steroidal anti-inflammatory drugs like aspirin and COX-2 inhibitor pain relievers like Celebrex do not appear to prevent mesothelioma, as they had hoped. Surviving Mesothelioma has just posted an article on the research. Click here to read it now.



Investigators in the Universitys School of Public Health and the National Centre for Asbestos Related Diseases say NSAIDS and COX-2 inhibitors did not keep mesothelioma from developing or improve survival in mice or people, although aspirin did appear to temporarily slow down disease development in mice.



Aspirin had a small but significant effect on disease latency (the time between asbestos exposure and first evidence of disease; p<0.05) but disease progression was not affected by the continued presence of the drug, reports lead author Dr. Cleo Robinson.



The study, published in Lung Cancer, also analyzed the impact of NSAIDS and COX-2 inhibitors in asbestos-exposed people and found no impact on their rate of mesothelioma.



This is disappointing news for those hoping for a simple way to prevent this deadly cancer, says Alex Strauss, Managing Editor of Surviving Mesothelioma. Although inflammation plays a role in mesothelioma development, this study suggests that it will take more than prevention of inflammation to prevent the disease.



To better understand the new study and its implications, especially if you or a loved one is on NSAIDS and is at risk for mesothelioma, see NSAIDS Temporarily Stave Off Mesothelioma in Mice, now available on the Surviving Mesothelioma website.



Robinson, C et al, Effect of NSAIDS and COX-2 Inhibitors on the Incidence and Severity of Asbestos-Induced Malignant Mesothelioma: Evidence from an Animal Model and a Human Cohort, August 18, 2014, Lung Cancer, Epub ahead of print, http://www.lungcancerjournal.info/article/S0169-5002(14)00347-X/abstract



For nearly ten years, Surviving Mesothelioma has brought readers the most important and ground-breaking news on the causes, diagnosis and treatment of mesothelioma. All Surviving Mesothelioma news is gathered and reported directly from the peer-reviewed medical literature. Written for patients and their loved ones, Surviving Mesothelioma news helps families make more informed decisions.











New Study Finds Aspirin May Delay Mesothelioma Development in Mice, Reports Surviving Mesothelioma

Mesothelioma Victims Center Shares A Different Side To Mesothelioma: How The United Kingdom Will Continue To See A Rise In Mesothelioma Cancer Among It's Citizens

(PRWEB) September 08, 2014


The Mesothelioma Victims Center says, “There is no way 100% of all individuals with mesothelioma are properly diagnosed in the United States. This results in many Americans never receiving compensation. Yes, we provide instant access to the nation’s premier mesothelioma compensation attorneys for a diagnosed victim, or their family, and yes, we create a tailor-made treatment option’s report for the victim that is focused on the best possible mesothelioma cancer treatment specialists in the surrounding area or their region.



The Center says, Mesothelioma is not unique to the United States, it is a global problem.



According the UK’s Independent on July 2nd, 2014, “The British Lung Foundation says mesothelioma diagnosis will continue to rise until around 2020 even though, around a year ago, it had been thought the peak would be reached in 2016. Symptoms of mesothelioma develop, on average, around 32 years after exposure to asbestos fibres with sufferers, once diagnosed, living an average of eight months. http://www.independent.co.uk/life-style/health-and-families/health-news/exclusive-urgent-call-for-research-into-mesothelioma-after-rise-in-number-of-deaths-9580081.html



Before hiring an attorney to advance a mesothelioma compensation claim, the Mesothelioma Victims Center is urging all diagnosed victims to first call them at 866-714-6466 and ensure they really are dealing with the nation’s most skilled mesothelioma compensation attorneys. http://MesotheliomaVictimsCenter.Com



The Mesothelioma Victims Center is urging individuals who were exposed to asbestos on a daily basis at a power plant, manufacturing facility, oil refinery, chemical plant, or while serving in the US Navy in the 1950’s, 1960’s, 1970’s, or 1980’s to get a annual medical check up that includes an x-ray focused on possible tumors in their lungs. They are also urging individuals such as this to tell their primary care physician about their exposure to asbestos. http://MesotheliomaVictimsCenter.Com



Information About Mesothelioma For Diagnosed Victims And Their Families From The Mesothelioma Victims Center:



According to the US Center for Disease Control the average age for a diagnosed victim of mesothelioma is 72 years old. Frequently victims of mesothelioma are initially misdiagnosed with pneumonia. This year between 2500, and 3000 US citizens will be diagnosed with mesothelioma. Mesothelioma is attributable to exposure to asbestos.



The states with the highest incidence of mesothelioma include Pennsylvania, Maine, New Jersey, West Virginia, Florida, Wyoming, and Washington. However, based on the calls the Mesothelioma Victims Center receives diagnosed victims could be in any state including California, New York, Texas, Massachusetts, Maryland, Virginia, North Carolina, Georgia, Louisiana, Oklahoma, Missouri, Ohio, Michigan, Iowa, Indiana, Illinois, Wisconsin, Minnesota, North Dakota, Montana, Nebraska, Kansas, Colorado, Utah, New Mexico, Arizona, Nevada, Idaho, Oregon, and Alaska.



High risk work groups for exposure to asbestos include US Navy Veterans, shipyard workers, oil refinery workers, power plant workers, manufacturing, or industrial workers, plumbers, electricians, auto mechanics, machinists, or construction workers. Typically the exposure to asbestos occurred in the 1950s, 1960s, 1970s, or 1980s. http://MesotheliomaVictimsCenter.Com



The Mesothelioma Victims Center says, Before you hire a mesothelioma attorney please call us at 866-714-6466, and compare the qualifications of who we consider to be the nation’s most skilled mesothelioma attorneys to any other lawyer, or law firm. When it comes to obtaining the best mesothelioma settlement, the quality of the attorney matters, as we would like to explain.” http://MesotheliomaVictimsCenter.Com



For more information about a rare form of cancer caused by exposure to asbestos called mesothelioma, please visit the US Centers For Disease Control’s web site: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5815a3.htm











Mesothelioma Victims Center Shares A Different Side To Mesothelioma: How The United Kingdom Will Continue To See A Rise In Mesothelioma Cancer Among It's Citizens

The Phillips Law Group Provides Tips for Early Cancer Detection and Urges the Southwest to Observe Mesothelioma Awareness Day on September 26, 2014

Phoenix, AZ (PRWEB) September 18, 2014


Mesothelioma is inextricably linked to asbestos exposure, and has an unusually low survival rate. The attorneys at Phillips Law Group are bringing attention to this disease through their observation of Mesothelioma Awareness Day on September 26, 2014, and by providing information to the public about tips which could lead to early detection of this deadly cancer(1).



TAKE STEPS AFTER OCCUPATIONAL EXPOSURE TO ASBESTOS



Workers who believe they may have been exposed to asbestos on the job should actively try to protect their health.



First, workers should quit smoking. Those who have been exposed to asbestos can significantly decrease their risk of mesothelioma lung cancer by quitting smoking as soon as possible.



Second, speak with a physician who is knowledgeable about the treatment of asbestos. Schedule yearly chest x-rays or lung function tests to catch any lung deterioration early.



Finally, seek treatment promptly for any lung or respiratory diseases, and always get vaccines against the flu, pneumonia, or any other disease which may affect the health of your lungs(2).



ASBESTOS EXPOSURE CAN CAUSE PROBLEMS DECADES LATER



Even though the use of asbestos is heavily regulated in the United States, approximately 3,000 people each year are still diagnosed with mesothelioma. The disease can lie dormant after exposure for between 20 to 50 years, meaning workers who were exposed decades earlier may just now be displaying symptoms.(3)



Workers who have been exposed to asbestos through their job and are now dealing with mesothelioma cancer or other asbestos-related illness may have legal recourse against their employers. Those who have been exposed to asbestos at work and believe they may have a claim may contact Phillips Law Group for a free, confidential consultation about their legal options.



ABOUT PHILLIPS LAW GROUP



The attorneys at Phillips Law Group have recovered millions of dollars in compensation for their clients, and have several offices conveniently located to serve a wide variety of legal needs. The Phoenix-based firm practices in multiple areas of the law, and offers free and confidential initial consultations. For more information on the firm, contact the Phillips Law Group by visiting http://www.phillipslaw.com or call (800) 706-3000.



Phillips Law Group


3101 North Central Ave


Suite 1500


Phoenix, AZ 85012


(602) 258-8888



Footnotes:


(1) Mesothelioma Applied Research Foundation, http://www.curemeso.org/site/c.duIWJfNQKiL8G/b.8578113/k.7E50/Mesothelioma_Awareness_Day__Mesothelioma_Applied_Research_Foundation.htm



(2) American Cancer Society, http://www.cancer.org/cancer/cancercauses/othercarcinogens/intheworkplace/asbestos



(3) Journal of Occupational Medicine, http://www.ncbi.nlm.nih.gov/pubmed/1494965











The Phillips Law Group Provides Tips for Early Cancer Detection and Urges the Southwest to Observe Mesothelioma Awareness Day on September 26, 2014

Mesothelioma Victims Center Points To A Recent NIH Research Grant To The University Of Pennsylvania As A Possible Game Changer For Some Diagnosed Victims

(PRWEB) September 19, 2014


The Mesothelioma Victims Center is constantly trying to evolve their information about how diagnosed victims of this rare form of cancer can get the best possible compensation for this rare form of cancer. One way this is achieved is through delivering updated information about treatment options. The group does their homework so all diagnosed victims and their family members can see what possibilities exist, and/or how treatment options are evolving.



The group says, On July 10, 2014, researchers at Perelman School of Medicine at the University of Pennsylvania in collaboration with the Roswell Park Cancer Institute received an $ 8 million grant from the National Cancer Institute to study the effects of photodynamic light therapy (PDT) in patients with malignant pleural mesothelioma. This is rare, aggressive and deadly cancer most often manifests itself in the lining of the lungs and is caused almost exclusively by exposure to asbestos.



What this means is funding for clinical trials and additional studies looking at the effects of PDT on the patients immune response, the tumor cell itself, and the blood vessels surrounding the tumor.



For attribution please visit:


http://www.uphs.upenn.edu/news/News_Releases/2014/07/meso/



The Center goes on to explain, The study, which expects to enroll 102 patients over four years, will administer Photofrin, a photosensitizing agent that makes cancer cells more sensitive to dying from light therapy, to trial participants 24 hours prior to surgery. Patients will undergo a radical pleurectomy, the removal of the pleura or lining of the lung along with the tumor cells contained within.



The Mesothelioma Victims Center wants to stress that any victim recently diagnosed with mesothelioma needs to call 866-714-6466, before proceeding with any legal endeavor.



The group says, Not only do we want to get you up-to-speed on what attorneys in the nation will produce the best possible financial compensation results for you, we also want to deliver information on the latest developments for mesothelioma treatment options and specific mesothelioma treatment centers that are the best-of-the-best in the US. No other group offers services like we do.” http://MesotheliomaVictimsCenter.Com



Information About Mesothelioma For Diagnosed Victims And Their Families From The Mesothelioma Victims Center:



High-risk groups for exposure to asbestos include US Navy Veterans, shipyard workers, oil refinery workers, power plant workers, manufacturing workers, plumbers, electricians, auto mechanics, machinists, or construction workers. Typically the exposure to asbestos occurred in the 1950s, 1960s, 1970s, or 1980s. US Navy Veterans account for a significant portion of all diagnosed victims of mesothelioma each year. According to the US Centers for Disease Control the average age for a diagnosed victim of mesothelioma is 72 years old. Each year between 2,500 and 3,000 US citizens will be diagnosed with mesothelioma. Mesothelioma is attributable to exposure to asbestos.



For more information about a rare form of cancer caused by exposure to asbestos called mesothelioma, please visit the US Centers For Disease Control’s website: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5815a3.htm



According to the CDC the states with the highest incidence of mesothelioma include Pennsylvania, Maine, New Jersey, West Virginia, Florida, Wyoming, and Washington. However, based on the calls the Mesothelioma Compensation Center receives diagnosed victims could be in any state including California, New York, Texas, Massachusetts, Maryland, Virginia, North Carolina, Georgia, Louisiana, Oklahoma, Missouri, Ohio, Michigan, Iowa, Indiana, Illinois, Wisconsin, Minnesota, North Dakota, Montana, Nebraska, Kansas, Colorado, Utah, New Mexico, Arizona, Nevada, Idaho, Oregon, Hawaii, or Alaska. http://MesotheliomaVictimsCenter.Com



The Mesothelioma Victims Center says, Call us at 866-714-6466 and we’ll see to it that you have on-the-spot access to the nations most skilled mesothelioma attorneys, because these incredibly skilled legal experts consistently get the best financial compensation results for their clients on a nationwide basis.” http://MesotheliomaVictimsCenter.Com











Mesothelioma Victims Center Points To A Recent NIH Research Grant To The University Of Pennsylvania As A Possible Game Changer For Some Diagnosed Victims

New Study Finds Link Between Genes and Mesothelioma Location, Reports Surviving Mesothelioma

Raleigh, NC (PRWEB) September 19, 2014


Cancer researchers in Japan have identified chromosomal abnormalities that appear to have an impact on where mesothelioma develops in the body. Click here to read Surviving Mesotheliomas new article on this important research.



Doctors with Nara Medical University report finding genetic differences between people with pleural mesothelioma (on the lung lining) and those with peritoneal mesothelioma (on the abdominal lining).



Our study suggests that the pathway of the genetic abnormality might vary between pleural and peritoneal malignant mesothelioma, writes lead investigator Dr. Maiko Takeda with the Universitys Department of Diagnostic Pathology.



To conduct the study published in the Journal of Clinical Pathology, Dr. Takeda and his colleagues analyzed tissue samples from 54 mesothelioma patients.



Understanding how genetics may impact mesothelioma development is an important step toward developing more effective gene-based treatments, says Surviving Mesotheliomas Managing Editor, Alex Strauss.



Full details of the study and its findings, including te exact chromosomal abnormalities associated with each type of mesothelioma, can be read in Study Finds Genes May Influence Site of Mesothelioma Tumors now available on the Surviving Mesothelioma website.



Takeda, M et al, Comparison of genomic abnormality in malignant mesothelioma by the site of origin, September 12, 2014, Journal of Clinical Pathology, Epub ahead of print, http://jcp.bmj.com/content/early/2014/09/12/jclinpath-2014-202465.abstract



For nearly ten years, Surviving Mesothelioma has brought readers the most important and ground-breaking news on the causes, diagnosis and treatment of mesothelioma. All Surviving Mesothelioma news is gathered and reported directly from the peer-reviewed medical literature. Written for patients and their loved ones, Surviving Mesothelioma news helps families make more informed decisions.











New Study Finds Link Between Genes and Mesothelioma Location, Reports Surviving Mesothelioma

New Research Links Soil Mineral with Mesothelioma Deaths in Mexican Village, According to Surviving Mesothelioma

Raleigh, NC (PRWEB) September 24, 2014


Researchers in Mexico say villagers there may be facing the same elevated risk of mesothelioma as people in certain parts of Turkey, and for the same reason. Surviving Mesothelioma has just posted an article on the new research. Click here to read it now.



Scientists at the Universidad Nacional Autonoma de Mexico say men in the village of Tierra Blanca, where the mineral erionite is prevalent, have a mesothelioma rate of 2.48 compared to a rate of about 1.75 among men in the U.S.



Erionite fibres were found in exposed rocks and soils, which can easily become airborne and be carried into streets and recreational areas near schools and homes, writes lead author Dr. M. Adrian Ortega-Guerrero.



The study in Occupational and Environmental Medicine indicated that, although asbestos, the primary cause of most mesothelioma, was also found in the village, it was only in trace amounts.



This study reminds us that we cannot take it for granted that asbestos is the only cause of mesothelioma, says Alex Strauss, Managing Editor of Surviving Mesothelioma. Especially for people in the Western U.S., erionite may pose a real and increasing health threat.



To learn more about this study and the mineral the CDC called an emerging North American hazard, see Soil Mineral Linked to Mesothelioma Deaths in Mexico, now available on the Surviving Mesothelioma website.



Ortega-Guerrero, MA et al, High incidence of lung cancer and malignant mesothelioma linked to erionite fibre exposure in a rural community in Central Mexico, September 17, 2014, Occupational and Environmental Medicine, Epub ahead of print, http://oem.bmj.com/content/early/2014/09/17/oemed-2013-101957.short?g=w_oem_ahead_tab



For nearly ten years, Surviving Mesothelioma has brought readers the most important and ground-breaking news on the causes, diagnosis and treatment of mesothelioma. All Surviving Mesothelioma news is gathered and reported directly from the peer-reviewed medical literature. Written for patients and their loved ones, Surviving Mesothelioma news helps families make more informed decisions.











New Research Links Soil Mineral with Mesothelioma Deaths in Mexican Village, According to Surviving Mesothelioma

Monday, December 1, 2014

Meso Foundation to Conduct a Media Disease Education Program on Mesothelioma Awareness Day on September 26, 2014

Alexandria, VA (PRWEB) September 25, 2014


The Mesothelioma Applied Research Foundation (Meso Foundation) a nonprofit organization dedicated to eradicating mesothelioma and easing the suffering caused by the cancer has announced its media education program to raise awareness of mesothelioma. On September 26th, the Meso Foundation will participate in interviews with multiple television and radio stations across the country as part of the organizations National Mesothelioma Awareness Day activities. The goal is to bring awareness, and subsequent attention and funding, to this neglected but extremely dangerous cancer.



The dire circumstances of those diagnosed with mesothelioma and lack of suitable therapy options make funding research and improvements in clinical care an urgent necessity. At this point, with only one FDA-approved treatment to work with, clinical trials are a crucial part of the diseases treatment paradigm. said Mary Hesdorffer, CRNP, the executive director of the Meso Foundation.



We are hopeful that through our efforts tomorrow, we will help educate the general public about this cancer and enlist their help as we work toward effective treatments. However, our goal is even more immediate: we want to ensure that those at risk for developing mesothelioma, and those who have already been diagnosed, know where to turn for life-saving help.



In addition to funding research and advocating for increased funding for mesothelioma, the Meso Foundation provides patients and their family members with free-of-charge expert help and guidance through their diagnosis. Help can be obtained by calling the organization or through its http://www.curemeso.org website.



Every year, 59,000 people worldwide die from mesothelioma, an aggressive cancer most commonly occurring in the lining of the lungs. Diagnosis of the disease, which is primarily caused by exposure to asbestos, is difficult and often delayed, and the median survival following diagnosis is only 12 months. Currently, there is only one drug approved by the U.S. Food & Drug Administration to treat the disease, extending life by approximately three months.



The Meso Foundation partnered with Verastem, Inc., for the Mesothelioma Awareness Day media campaign. Verastem provided the funding to help promote disease awareness and education. Verastem is conducting the COMMAND Study (http://www.COMMANDmeso.com) for patients with malignant pleural mesothelioma in many countries worldwide.



About The Mesothelioma Applied Research Foundation


The Meso Foundation is the only 501(c)(3) nonprofit organization dedicated to eradicating mesothelioma and easing the suffering caused by this cancer. The Meso Foundation actively seeks philanthropic support to fund mesothelioma research; provide patient support services and education; and advocate Congress for increased federal funding for mesothelioma research. The Meso Foundation is the only non-government funder of peer-reviewed scientific research to develop life-saving treatments for this extremely aggressive cancer. To date, the Foundation has awarded over $ 8.7 million to research. More information is available at http://www.curemeso.org.











Meso Foundation to Conduct a Media Disease Education Program on Mesothelioma Awareness Day on September 26, 2014

Volunteers Raising Awareness of Deadly Cancer on Today Show On Sept. 26

Alexandria, VA (PRWEB) September 25, 2014


The Mesothelioma Applied Research Foundation (Meso Foundation), the national charity dedicated to ending mesothelioma, has announced that for the fifth consecutive year, on Mesothelioma Awareness Day, its volunteers will be attending the Today show on Rockefeller Plaza, in New York to raise awareness of the neglected, but deadly, cancer. The show starts at 7 AM Eastern Time.



In the past years, mesothelioma community members have received attention from Al Roker and Savannah Guthrie.



Mesothelioma Awareness Day, established by Meso Foundation volunteers in 2004, has been the driving force behind the movement to bring more attention and funding to this cancer.



In the last ten years, through various activities, the Meso Foundation and its volunteers have been able to obtain “National Mesothelioma Awareness Day” proclamations by both the U.S. Senate and the House of Representatives, have raised nearly a million dollars, have received local government proclamations in their states and localities, and have received dozens of instances of media coverage for their stories, events, and activities.



Mesothelioma is a malignant tumor of the lining of the lung, abdomen, or heart known to be caused by exposure to asbestos. With the life expectancy of less than one year after diagnosis, medical experts consider it one of the most aggressive and deadly of all cancers. An estimated one-third of those who develop mesothelioma were exposed while serving in the Navy or working in shipyards. Currently, few treatment options exist. There is no cure.



About the Mesothelioma Applied Research Foundation


The Meso Foundation is the only 501(c)(3) nonprofit organization dedicated to eradicating mesothelioma and easing the suffering caused by this cancer. The Meso Foundation actively seeks philanthropic support to fund mesothelioma research; provide patient support services and education; and advocate Congress for increased federal funding for mesothelioma research. The Meso Foundation is the only non-government funder of peer-reviewed scientific research to develop life-saving treatments for this extremely aggressive cancer. To date, the Foundation has awarded over $ 8.7 million to research. More information is available at http://www.curemeso.org.


###











Volunteers Raising Awareness of Deadly Cancer on Today Show On Sept. 26

New York Law Firm Announces Progress on Low Testosterone Drug Heart Attack Cases

(PRWEB) September 30, 2014


The Federal Court System has assigned all lawsuits relating to low testosterone drugs and heart attacks to the Southern District of Illinois (In re Testosterone Replacement Therapy Products Liability Litigation, MDL 2545). Progress on the cases is being made and the most recent case management conference was held on September 23.



The FDA states, The benefits of testosterone treatments for healthy, aging men are unproven, and that the drugs could be risky. Men who take low testosterone treatments have been found to have higher rates of heart problems and many more side effects (See fda.gov/downloads/drugs/


drugsafety/ucm383909.pdf).



According to the Urology Care Foundation, Low testosterone treatment product usage has increased since the early 2000s for middle aged men because of aggressive marketing that portrayed testosterone drugs as a fountain of youth for low energy and low sex drive in aging men. The marketing tactics focus the ads to play on mens insecurities regarding the normal aging process of life and emphasis it as if its not normal. “Many of these products are marketed like some type of fountain of youth, ignoring the real danger to Men’s Health that it causes”, states New York Attorney Rudolph Migliore.



The FDA found that about 25% of the men who are prescribed testosterone have not had their testosterone levels tested properly or at all (see fda.gov/drugs/drugsafety/ucm401746.htm). In addition, about 60% of the men prescribing involved primary care doctors, while just about 20% of the drugs are prescribed by specialists such as endocrinologists and urologists. The FDA and experts state, The label on low testosterone products should be limited to men with serious medical conditions, such as pituitary gland problems.



If you or a loved one has been treated for low testosterone and suffered a heart attack, stroke, pulmonary embolism or cardiac event the Commack, NY law firm of Rudolph F.X. Migliore, P.C. is currently investigating cases involving testosterone therapy treatments which include various prescription drugs such as AndroGel, Bio-T-Gel, Dep-Testerone, Testim, Axiron, Delatesty, Fortesta, Testopel, Androderm, and Striant.



About Us – Rudolph F. X. Migliore, P.C.


The law office of Rudolph F. X. Migliore, P.C. has represented clients in a wide range of product liability cases in the last three decades and has worked with nationally recognized associated firms to reach successful verdicts. The Long Island, NY law firm of Rudolph F. X. Migliore, P. C. extends its practice of legal services to medical malpractice, defective medications, defective medical devices, asbestos, mesothelioma and lung cancer-related cases, criminal defense, and traffic.











New York Law Firm Announces Progress on Low Testosterone Drug Heart Attack Cases

Asbestos Attorney Recognized by Super Lawyers 2014 Edition

NEW YORK, New York (PRWEB) September 30, 2014


Asbestos attorney Amber R. Long, an associate at Levy Konigsberg LLP (LK), a nationally-recognized mesothelioma law firm, has been selected to the Super Lawyers 2014 New York Metro Rising Stars list. Each year, no more than 2.5 percent of the lawyers in the state are selected by the research team at Super Lawyers to receive this honor.



Amber joined LK in 2006 and, initially, worked in the firms national asbestos litigation department. She represented mesothelioma and lung cancer victims in lawsuits filed around the country including in Delaware, Minnesota, Wisconsin, and Louisiana. Recently, she has joined the firms New York City asbestos litigation department.



Amber takes pride in representing hard working men and women suffering from debilitating and often deadly cancer as a result of their exposure to asbestos. She is highly skilled in all aspects of asbestos litigation from the initial client meeting through trial and appellate practice.



In addition to her asbestos experience, Amber assisted in the litigation of three cases in the Southern District of New York against tobacco companies on behalf of the families of people who began smoking as children, struggled to quit smoking, and eventually died of lung cancer. In the course of this litigation, Amber and LK partner, Jerome Block, obtained multimillion dollar verdicts on behalf of two separate families against Brown & Williamson (successor to American Tobacco Company) (1) and Philip Morris USA, Inc (2).



Amber is a member of several professional associations, including the American Association for Justice, the New York State Bar Association, and the New York City Bar Association. She is admitted to practice law in New York, New Jersey, before the United States District Courts for the Eastern and Southern Districts of New York and for the District of Connecticut, and before the Second Circuit Court of Appeals. Amber earned a Bachelor of Arts degree in Psychology from Cornell University in 2002. In 2005, she graduated magna cum laude from Brooklyn Law School.



Levy Konigsberg LLP has been representing mesothelioma and asbestos lung cancer victims for more than 25 years.



Super Lawyers, a Thomson Reuters business, is a rating service of outstanding lawyers from more than 70 practice areas who have attained a high degree of peer recognition and professional achievement. The annual selections are made using a patented multiphase process that includes a statewide survey of lawyers, an independent research evaluation of candidates and peer reviews by practice area. The result is a credible, comprehensive and diverse listing of exceptional attorneys.



(1) Eileen A. Clinton, on behalf of herself and as administratrix of the estate of William A. Champagne, Jr., vs. Brown & Williamson Holdings, Inc., as successor by merger to American Tobacco Company, and Philip Morris USA Inc., No. 05 Civ. 9907 (CS) (LMS) (S.D.N.Y);


(2) Florence Mulholland, on behalf of herself and as administratrix of the estate of David Mulholland, vs. Philip Morris USA Inc., No. 05 Civ. 9908 (CS) (S.D.N.Y).











Asbestos Attorney Recognized by Super Lawyers 2014 Edition

Meso Foundation and University of Chicago Medicine Present Chicago Conference on Mesothelioma

Alexandria, VA (PRWEB) September 30, 2014

The Mesothelioma Applied Research Foundation (Meso Foundation) has released the agenda for its October 10th regional conference, which will take place at the Palmer House Hilton hotel in Chicago, Illinois, in collaboration with the University of Chicago Medicine. The conference is a one-day event geared to patients and family members, covering a variety of topics related to mesothelioma and presented by local and regional area experts.


The agenda can be viewed on the Meso Foundations website at http://www.curemeso.org/chicago.


The event begins at 9:30am and concludes with a cocktail reception at 5pm. The registration cost is $ 25, and includes breakfast and lunch. Online registration is available.